TMCNet article

The House approval last week of a measure to reauthorize the Small Business Innovation Research (SBIR) program was a positive step for the biotech industry. The question now is if the Senate will follow suit.

In a 368-43 vote Wednesday night, the House passed H.R. 5819, which reauthorizes the SBIR program. The Senate has yet to introduce a companion bill, but several members of that chamber, led by Sen. John Kerry (D-Mass.), chairman of the Senate Small Business and Entrepreneurship Committee, have been working on legislation.

To read the rest of this article, please click here.